HCA Healthcare: 3 Key Takeaways for Long-Term Investors

Source The Motley Fool

Key Points

  • Same facility equivalent admissions increased 3% in the third quarter.

  • HCA Healthcare repurchased approximately $3 billion of outstanding shares.

  • Exchange equivalent admissions declined 19% compared to prior year.

  • 10 stocks we like better than HCA Healthcare ›

On its third-quarter 2026 earnings call, held on Oct. 27, 2026, HCA Healthcare (NYSE:HCA) announced that patient volume expanded while shifting coverage models pressured top-line margins. A hospital operator's ability to offset policy-driven margin shifts through operational efficiency determines long-term shareholder returns, and it doesn't happen without cost discipline.

Three things management said stand out.

1. Insurance Coverage Shifts Drive Uninsured Patient Volume Growth

Patients losing coverage through public health insurance exchanges are transitioning directly into uninsured status. This shift creates headwinds because uninsured patients don't generate the same revenue per admission as commercially insured accounts.

Like the second quarter, we continue to see patients who have lost coverage on the exchanges migrate almost 1-for-1 to uninsured. This 1-for-1 migration makes up approximately 80% of our uninsured volume growth.
-- Michael A. Marks, Chief Financial Officer

2. Enterprise Resiliency Programs Generate Structural Cost Discipline

Management relies on technology upgrades and shared service expansion to lower unit operating costs. These internal initiatives help keep expenses from creeping higher across the hospital network.

So when we start thinking about cost in 2027, as I mentioned in my comments, we do anticipate more value coming from our resiliency program broadly within our networks, and from a cost standpoint overall for the company.
-- Samuel N. Hazen, Chief Executive Officer

3. Multiyear Growth Targets Depend on Operational Initiatives and Policy Stability

Long-term targets require stabilizing insurance coverage so the business doesn't face ongoing payer mix friction under HR1, the federal healthcare legislation. Management expects internal digital and network initiatives to drive value creation.

First, we move past the most significant effects on payer mix, from the exchanges. Second, we assume no material policy changes beyond HR1. And finally, we have a set of strategic initiatives including digital transformation network development, and ongoing resiliency programs that generate significant value.
-- Samuel N. Hazen, Chief Executive Officer

Looking Ahead

Patient volume is expanding across core service lines, and performance is tracking toward the top end of full-year targets.

Given our third quarter performance, we currently expect to be in the upper half of our guidance ranges for the year.
-- Michael A. Marks, Chief Financial Officer

Scale across 43 markets and continuous capital investment into outpatient centers provide structural advantages. Management is watching insurance enrollment trends and pricing discipline.

As we look to the future, I am confident that HCA Healthcare has the right people, the right process, and the financial position to achieve our long-term objectives.
-- Samuel N. Hazen, Chief Executive Officer

Should you buy stock in HCA Healthcare right now?

Before you buy stock in HCA Healthcare, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and HCA Healthcare wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $341,966!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,146,819!*

Now, it’s worth noting Stock Advisor’s total average return is 852% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 7, 2026.

The Motley Fool has positions in and recommends HCA Healthcare. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Forecast: Gold Falls Below $4,100, Can October Nonfarm Payrolls Fuel Another Rally?As of the Asian session on Friday (November 6), gold prices (XAUUSD) pulled back following consecutive rebounds, dropping about 0.85% intraday to trade near $4,050. Earlier, gold climbed
Author  TradingKey
Yesterday 08: 10
As of the Asian session on Friday (November 6), gold prices (XAUUSD) pulled back following consecutive rebounds, dropping about 0.85% intraday to trade near $4,050. Earlier, gold climbed
placeholder
Micron's $4.5 billion Taiwan fab won't make a chip until 2028 — the market sold it as a 2026 problemMicron fell 17.46% to $656.39 after Bloomberg reported construction at its $4.5 billion Taoyuan Fab 11E had all but halted over a labor dispute. The plant was not due online until 2028, so no 2026 output is lost. With FY27 EPS consensus near $160 and 2027 HBM sold out, the selloff is a peak-cycle multiple reset, not a demand collapse — and $650 is the line that separates the two.
Author  Irene Q.
Yesterday 03: 28
Micron fell 17.46% to $656.39 after Bloomberg reported construction at its $4.5 billion Taoyuan Fab 11E had all but halted over a labor dispute. The plant was not due online until 2028, so no 2026 output is lost. With FY27 EPS consensus near $160 and 2027 HBM sold out, the selloff is a peak-cycle multiple reset, not a demand collapse — and $650 is the line that separates the two.
placeholder
Gold's $250 week runs into the last payrolls before DecemberSpot gold traded at $4,080.79 after a roughly 6% weekly rally from the Oct 30 low of $3,869.85, touching $4,146.63 on Nov 5. Three bids are stacked into the move: real-rate relief, record official-sector buying, and a geopolitical premium. Tonight's October payrolls (+65K consensus, 4.2% unemployment) decide which bid survives, with $4,000 and $4,200 as the two lines.
Author  Irene Q.
Yesterday 03: 03
Spot gold traded at $4,080.79 after a roughly 6% weekly rally from the Oct 30 low of $3,869.85, touching $4,146.63 on Nov 5. Three bids are stacked into the move: real-rate relief, record official-sector buying, and a geopolitical premium. Tonight's October payrolls (+65K consensus, 4.2% unemployment) decide which bid survives, with $4,000 and $4,200 as the two lines.
placeholder
TradingKey Daily Market Brief: Nasdaq Falls Over 5%, AI Stocks Plunge as Nvidia Drops Over 9%, Micron Falls Over 17%, SanDisk Drops Over 22% During the Asian trading session on November 6, the three major U.S. stock indices tumbled across the board overnight as the sell-off across the AI data center suppl
Author  TradingKey
Yesterday 01: 41
During the Asian trading session on November 6, the three major U.S. stock indices tumbled across the board overnight as the sell-off across the AI data center suppl
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 6, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 6, 2026. Read on for the details.
Author  Mitrade
Yesterday 01: 36
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 6, 2026. Read on for the details.
goTop
quote